Michael A. Schwarzschild
Affiliations: | Neurology | Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States |
Google:
"Michael Schwarzschild"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Nikolaus R. McFarland | post-doc | 2008-2010 | Massachusetts General Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Olsen A, Locascio J, Tuncali I, et al. (2023) Health phenome of Parkinson's patients reveals prominent mood-sleep cluster. Research Square |
| Flores-Torres MH, Bjornevik K, Zhang X, et al. (2023) Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update. Parkinsonism & Related Disorders. 119: 105965 |
| Srivastava P, Nishiyama S, Zhou F, et al. (2023) Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Xia N, Madore V, Albalakhi A, et al. (2023) Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson's disease. Scientific Reports. 13: 15539 |
| Palacios N, Wilkinson J, Bjornevik K, et al. (2023) Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Annals of Neurology |
| Di Luca DG, Macklin EA, Hodgeman K, et al. (2023) Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials. Neurology. Clinical Practice. 13: e200113 |
| Crotty GF, Keavney JL, Alcalay RN, et al. (2022) Planning for Prevention of Parkinson Disease: Now Is the Time. Neurology. 99: 1-9 |
| Patterson CG, Joslin E, Gil AB, et al. (2022) Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 23: 855 |
| Zhang X, Molsberry SA, Schwarzschild MA, et al. (2022) Association of Diet and Physical Activity With All-Cause Mortality Among Adults With Parkinson Disease. Jama Network Open. 5: e2227738 |
| Crotty GF, Schwarzschild MA. (2022) What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs. Neurology. 99: 34-41 |